STAT

Opinion: Open science, publishing, and public research support: Could Trump have it right?

Taxpayers pony up for research they will have difficulty getting access to, and at the same time subsidize companies that exploit students, faculty members, and researchers. That has to change.
President Trump

In the three years since Donald Trump was inaugurated as president, I have rarely supported anything he proposed. And for nearly 50 years as an academic researcher, I have almost always sided with the professional research establishment. Yet on one issue I now find myself siding with the president and opposing the scientific establishment.

In December, E&E News reported that the president was considering an executive action requiring that all federally funded research become available to the public immediately upon publication. After all, taxpayers paid for much of this research, which could enhance their health or quality of life, and it should become open science.

The current system allows publishers to collect substantial fees in order to provide access to articles

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks